Study likely spells end for anti-bleeding drug (AP)AP - An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/ap/heart_drug.html